Infliximab in the Treatment of Severe, Steroid-Refractory Ulcerative Colitis: A Pilot Study
Top Cited Papers
Open Access
- 1 May 2001
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 7 (2), 83-88
- https://doi.org/10.1097/00054725-200105000-00001
Abstract
Summary. We report the experience of 11 patients (of 60 planned patients) enrolled in a double-blind, placebo-controlled clinical trial of infliximab in patienKeywords
This publication has 19 references indexed in Scilit:
- Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha.Gut, 1997
- Tumour necrosis factor and Crohn's disease.Gut, 1997
- Biologic Therapy for Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 1997
- Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease.Gut, 1996
- Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's diseaseJournal of Clinical Immunology, 1996
- Pro‐inflammatory cytokines in inflammatory bowel disease.Alimentary Pharmacology & Therapeutics, 1996
- Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid TherapyNew England Journal of Medicine, 1994
- Tumor necrosis factor α-producing cells in the intestinal mucosa of children with inflammatory bowel diseaseGastroenterology, 1994
- Cytokines (Immunoinflammatory Hormones) and Their Natural Regulation in Inflammatory Bowel Disease (Crohn’s Disease and Ulcerative Colitis): A ReviewDigestive Diseases, 1994
- Tumour necrosis factor alpha in stool as a marker of intestinal inflammationThe Lancet, 1992